Clinical Trials Directory

Trials / Sponsors / Delcath Systems Inc.

Delcath Systems Inc.

Industry · 11 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followe
Metastatic Breast Cancer in the Liver
Phase 22026-01-29
RecruitingEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followe
Refractory Metastatic Colorectal Cancer
Phase 22025-08-05
UnknownAn Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Do
Metastatic Ocular Melanoma, Metastatic Uveal Melanoma
Phase 32022-06-10
UnknownPercutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Bile Duct Cancer, Intrahepatic Cholangiocarcinoma
Phase 2 / Phase 32018-04-10
CompletedPercutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
Melanoma, Ocular
Phase 32016-02-01
UnknownRegistry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignan
Hepatic Malignant Neoplasm Primary Non-Resectable
—2016-01-14
WithdrawnSequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unr
Hepatocellular Carcinoma (HCC)
Phase 22014-10-01
TerminatedMelphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carc
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma
Phase 22014-06-01
CompletedHepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable
Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer
Phase 32006-02-01
CompletedHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Can
Cancer
Phase 22004-09-01
No Longer AvailableExpanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets
Metastatic Liver Cancer, Ocular Melanoma, Cutaneous Melanoma
——